Literature DB >> 24379398

Coordinated regulation of serum- and glucocorticoid-inducible kinase 3 by a C-terminal hydrophobic motif and Hsp90-Cdc37 chaperone complex.

Yuanzhong Wang1, Wanping Xu, Dujin Zhou, Len Neckers, Shiuan Chen.   

Abstract

Serum- and glucocorticoid-inducible kinase 3 (SGK3) mediates a variety of cellular processes including membrane transport, cell proliferation, and survival, and it has been implicated in Akt-independent signaling downstream of oncogenic PIK3CA mutations (activating mutations in the α catalytic subunit of PI3K) in human cancers. However, the regulation of SGK3 is poorly understood. Here we report that SGK3 stability and kinase activation are regulated by the Hsp90-Cdc37 chaperone complex. Hsp90-Cdc37 associates with the kinase domain of SGK3 and acts in concert with a C-terminal hydrophobic motif of SGK3 to prevent Hsp70 association and ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein)-mediated degradation. Phosphorylation of hydrophobic motif triggers release of Cdc37 and concomitant association of 3-phosphoinositide dependent kinase 1 (PDK1) to activate SGK3. Our study provides new insights into regulation of SGK3 stability and activation and the rationale for application of Hsp90 inhibitors in treating SGK3-dependent cancers.

Entities:  

Keywords:  CHIP; Cdc37; Hsp90; Hydrophobic Motif; Molecular Chaperone; PI 3-Kinase (PI3K); Protein Stability; SGK3; Ubiquitination

Mesh:

Substances:

Year:  2013        PMID: 24379398      PMCID: PMC3931044          DOI: 10.1074/jbc.M113.518480

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4.

Authors:  Thomas Slagsvold; Adriano Marchese; Andreas Brech; Harald Stenmark
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

3.  Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3.

Authors:  Maude Tessier; James R Woodgett
Journal:  J Biol Chem       Date:  2006-06-21       Impact factor: 5.157

4.  A novel N-terminal hydrophobic motif mediates constitutive degradation of serum- and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway.

Authors:  Agata M Bogusz; Deanna R Brickley; Travis Pew; Suzanne D Conzen
Journal:  FEBS J       Date:  2006-07       Impact factor: 5.542

Review 5.  Targeting the dynamic HSP90 complex in cancer.

Authors:  Jane Trepel; Mehdi Mollapour; Giuseppe Giaccone; Len Neckers
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

6.  SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells.

Authors:  Yuanzhong Wang; Dujin Zhou; Sheryl Phung; Selma Masri; David Smith; Shiuan Chen
Journal:  Mol Endocrinol       Date:  2010-11-17

7.  An amphipathic helix targets serum and glucocorticoid-induced kinase 1 to the endoplasmic reticulum-associated ubiquitin-conjugation machinery.

Authors:  Maria Francisca Arteaga; Lin Wang; Tommer Ravid; Mark Hochstrasser; Cecilia M Canessa
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-17       Impact factor: 11.205

8.  Activation of the Akt-related cytokine-independent survival kinase requires interaction of its phox domain with endosomal phosphatidylinositol 3-phosphate.

Authors:  J V Virbasius; X Song; D P Pomerleau; Y Zhan; G W Zhou; M P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

9.  Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer.

Authors:  Corey Speers; Anna Tsimelzon; Krystal Sexton; Ashley M Herrick; Carolina Gutierrez; Aedin Culhane; John Quackenbush; Susan Hilsenbeck; Jenny Chang; Powel Brown
Journal:  Clin Cancer Res       Date:  2009-10-06       Impact factor: 12.531

10.  SGK3 is associated with estrogen receptor expression in breast cancer.

Authors:  Jun Xu; Ma Wan; Quanyuan He; Roland L Bassett; Xiaoyong Fu; Albert C Chen; Fengtao Shi; Chad J Creighton; Rachel Schiff; Lei Huo; Dan Liu
Journal:  Breast Cancer Res Treat       Date:  2012-05-11       Impact factor: 4.872

View more
  9 in total

1.  MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.

Authors:  Huailei Liu; Chenguang Li; Chen Shen; Fei Yin; Kaikai Wang; Yaohua Liu; Bingjie Zheng; Weiguang Zhang; Xu Hou; Xin Chen; Jianing Wu; Xiaoxiong Wang; Chen Zhong; Jiakang Zhang; Huaizhang Shi; Jing Ai; Shiguang Zhao
Journal:  J Neurooncol       Date:  2015-02-27       Impact factor: 4.130

2.  SGK3 sustains ERα signaling and drives acquired aromatase inhibitor resistance through maintaining endoplasmic reticulum homeostasis.

Authors:  Yuanzhong Wang; Dujin Zhou; Sheryl Phung; Charles Warden; Rumana Rashid; Nymph Chan; Shiuan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-07       Impact factor: 11.205

3.  TXNIP Links Anticipatory Unfolded Protein Response to Estrogen Reprogramming Glucose Metabolism in Breast Cancer Cells.

Authors:  Yuanzhong Wang; Shiuan Chen
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 5.051

4.  SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1.

Authors:  Yuanzhong Wang; Dujin Zhou; Shiuan Chen
Journal:  Mol Endocrinol       Date:  2014-04-16

5.  Amphiregulin retains ERα expression in acquired aromatase inhibitor resistant breast cancer cells.

Authors:  Yuanzhong Wang; Yen-Dun Tony Tzeng; Gregory Chang; Xiaoqiang Wang; Shiuan Chen
Journal:  Endocr Relat Cancer       Date:  2020-12       Impact factor: 5.678

6.  Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell lines.

Authors:  Stefan Hausmann; Evelyn Brandt; Carolin Köchel; Hermann Einsele; Ralf C Bargou; Ruth Seggewiss-Bernhardt; Thorsten Stühmer
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

7.  Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells.

Authors:  Xiaoli Li; Guangbei Zhu; Xintong Yao; Ning Wang; Ronghui Hu; Qingxin Kong; Duanfang Zhou; Liangyuan Long; Jiali Cai; Weiying Zhou
Journal:  Onco Targets Ther       Date:  2018-12-11       Impact factor: 4.147

Review 8.  Chaperone-assisted E3 ligase CHIP: A double agent in cancer.

Authors:  Sunny Kumar; Malini Basu; Mrinal K Ghosh
Journal:  Genes Dis       Date:  2021-09-01

9.  HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death.

Authors:  A V Jacobsen; K N Lowes; M C Tanzer; I S Lucet; J M Hildebrand; E J Petrie; M F van Delft; Z Liu; S A Conos; J-G Zhang; D C S Huang; J Silke; G Lessene; J M Murphy
Journal:  Cell Death Dis       Date:  2016-01-14       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.